Company
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals has 17 drugs tracked on RxWires: 4 in Phase 3, 1 in Phase 2/3, 7 in Phase 2, 5 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BCX7353 capsules | Phase 3 | Hereditary Angioedema, HAE |
| Peramivir | Phase 3 | Seasonal Influenza |
| avoralstat | Phase 3 | Hereditary Angioedema |
| berotralstat | Phase 3 | Hereditary Angioedema |
| BCX4161 | Phase 2/3 | Hereditary Angioedema |
| ulodesine | Phase 2 | Gout |
| BCX9930 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria |
| Forodesine Hydrochloride Sterile Solution, 5 mg/mL | Phase 2 | Leukemia |
| BCX4208 | Phase 2 | Gout |
| Forodesine 200 mg | Phase 2 | Cutaneous T-cell Lymphoma (CTCL), |
| BCX9930 monotherapy | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Eculizumab | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| BCX4430 | Phase 1 | Filovirus Infections |
| galidesivir | Phase 1 | Marburg Virus Disease |
| BCX17725 | Phase 1 | Netherton Syndrome |
| BCX7353 and probes | Phase 1 | Hereditary Angioedema |
| BCX10013 | Phase 1 | Paroxysmal Nocturnal Hemoglobinuria |
Latest
- biocryst pharmaceuticals filed 8-K
- biocryst pharmaceuticals filed 8-K
- biocryst pharmaceuticals filed 8-K
- biocryst pharmaceuticals filed 8-K
- biocryst pharmaceuticals filed 8-K
Follow BioCryst Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.